Modification on the O-glucoside of Sergliflozin-A: A new strategy for SGLT2 inhibitor design.
Bioorganic & Medicinal Chemistry Letters(2016)
摘要
Poor pharmacokinetic stability is one of the issues of O-glucoside SGLT2 inhibitors in clinical trials, hence C-glucoside inhibitors have been developed and extensively applied. Herein, we provided an alternative approach to improve the pharmacokinetic stability of such inhibitors. Nine derivatives of Sergliflozin-A with modifications on the O-glucoside fragment were prepared, among which the 4-O-methyl derivative exhibited similar pharmacodynamics potency in excreted glucose urine test. Most attractively, significantly increased pharmacokinetic stability was observed for 4-O-methyl derivative of O-glucosides. This work proved that modification on the O-glucoside fragment could be a promising approach to the future SGLT2 inhibitor design.
更多查看译文
关键词
SGLT2 inhibitor,Sergliflozin-A,O-Glucoside,Pharmacokinetic stability
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络